Mosspiration Biotech ApS: Financial statements 2020
CVR: 37414506
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Mosspiration Biotech ApS (CVR 37414506) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 37,761 and a net result of DKK 37,488 compared with DKK 9,135 the year before. That is a decrease of 26% compared with the year before. Equity in the 2020 report amounted to DKK 2,244. The solvency ratio was 9.4%.
- Gross Profit
- DKK 37,761
- Profit/Loss
- DKK 37,488
- Equity
- DKK 2,244
- Total Assets
- DKK 23,944
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 38 t. | 37 t. | 2 t. | - |
| 2019 | - | 51 t. | 9 t. | -35 t. | - |
| 2018 | - | 160 t. | -121 t. | -44 t. | - |
| 2017 | - | 255 t. | 67 t. | 77 t. | 1 |
| 2016 | - | -13 t. | -10 t. | 10 t. | - |
Official annual report
How creditworthy is Mosspiration Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of October 30, 2020, Hansol Bae has stepped down as director of Mosspiration Biotech ApS.
Mosspiration Biotech ApS has published its annual report for 2019. Gross profit came to DKK 51,016, and the net result was DKK 9,135.
About Mosspiration Biotech ApS
Mosspiration Biotech ApS was a Danish company of the type Anpartsselskab based in Glostrup, founded in 2016. The company has been dissolved on 14 August 2024. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named Mosspiration Biotech IVS. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -6,233 and a net result of DKK -6,233 compared with DKK -20,393 the year before. Equity in the 2023 report amounted to DKK 4,088.